2024
Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors
Bang A, Fay C, LeBoeuf N, Etaee F, Leventhal J, Sibaud V, Arbesman J, Wang J, Kwong B. Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors. Breast Cancer Research And Treatment 2024, 204: 643-647. PMID: 38224427, DOI: 10.1007/s10549-023-07217-2.Peer-Reviewed Original ResearchVitiligo-like lesionsProgression-free survivalSurvival benefitMedian progression-free survivalAssociated with survival benefitSkin-directed therapiesMetastatic breast cancerSun-exposed areasPotential treatment optionCyclin-dependent kinase 4ConclusionClinical characteristicsMild repigmentationRuxolitinib creamTopical ruxolitinibMethodsRetrospective reviewResultsMedian ageClinical characteristicsCase reportTreatment optionsBreast cancerKinase inhibitorsCDK4/6iInternational cohortPatientsQuality of life
2022
Update of pathophysiology and treatment options of seborrheic keratosis
Gorai S, Ahmad S, Raza S, Khan H, Raza M, Etaee F, Cockerell C, Apalla Z, Goldust M. Update of pathophysiology and treatment options of seborrheic keratosis. Dermatologic Therapy 2022, 35: e15934. PMID: 36226729, DOI: 10.1111/dth.15934.Peer-Reviewed Original ResearchConceptsSeborrheic keratosisUpdate of pathophysiologyHuman papillomavirus infectionAmyloid-associated proteinsMale gender preponderanceYounger age groupsTerms of treatmentExpression of factorsPapillomavirus infectionPrecise pathogenesisTopical agentsGender preponderanceLocal anesthesiaTreatment optionsIndependent associationCosmetic concernsBenign tumorsMalignant tumorsCommon reasonAge groupsAlternative diagnostic techniquesFGFR-3Safe methodYoung adultsCosmetic purposes